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Two novel antibacterial peptides of clostridial species were purified, N-terminally sequenced, and charac-
terized. Moreover, their structural genes were identified. Closticin 574 is an 82-amino-acid bacteriocin pro-
duced by Clostridium tyrobutyricum ADRIAT 932. The supernatant of the producing strain showed a high level
of activity against the indicator strain C. tyrobutyricum. The protein is synthesized as a preproprotein that is
possibly secreted via the general secretion pathway, after which it is hydrolyzed at an Asp-Pro site. Circularin
A is produced by Clostridium beijerinckii ATCC 25752 as a prepeptide of 72 amino acids. Cleavage of the
prepeptide between the third leucine and fourth valine residues followed by a head-to-tail ligation between the
N and C termini creates a circular antimicrobial peptide of 69 amino acids. The unusually small circularin A
leader peptide of three amino acids is cleaved off in this process. The supernatant of C. beijerinckii ATCC 25752
showed a broad antibacterial activity range.
Clostridia have a negative image as many species are known
as pathogens (50), toxin producers (50), and food-spoilage
bacteria (36). Various clostridia produce bacteriocins, but de-
spite their long history as a means of typing clostridia (33, 39),
only little sequence, functional, or structural information is
available on these antibacterial peptides. The few clostridial
bacteriocins that have been further characterized are BCN5
and boticin B (12, 18). BCN5 is a large (97-kDa) UV-inducible
protein produced by Clostridium perfringens (18). Boticin B is
produced by Clostridium botulinum as a small peptide with a
predicted size of 50 amino acid residues (12). Little is known
about the regulation of production or secretion of these bac-
teriocins. Generally, bacteriocins are small ribosomally synthe-
sized antimicrobial peptides (27, 35). They are mostly mem-
brane permeabilizing and cationic, and they typically comprise
fewer than 50 amino acid residues (35). Bacteriocins can be
used as an additive to food products to prevent the growth of
spoilage bacteria (10). Klaenhammer divided bacteriocins into
four classes (35). Class I bacteriocins, known as lantibiotics,
contain posttranslationally modified residues such as lanthi-
onine, -methyl lanthionine, and dehydrated residues. Class II
bacteriocins lack these modifications and are linear peptides
(35, 44). Class III contains the large, heat-labile bacteriocins.
Class IV bacteriocins are complex molecules composed of pro-
tein and chemical moieties. Both class I and class II bacterio-
cins have been intensively studied, and more than 20 and 100
representatives are known, respectively.
The subclass IIc (class II bacteriocins other than the pedi-
ocin-like bacteriocins or the two-peptide bacteriocins) contains
a few examples of bacteriocins that are produced as circular
molecules. This circularization is the result of a head-to-tail
peptide bond formation of a prepeptide. Bacteriocins with this
typical structure are microcin J25, gassericin A, and AS-48/
Bac21 (6, 31, 40, 59). Microcin J25 is produced by Escherichia
coli as a 58-amino-acid precursor which, after processing,
yields a cyclic peptide of 21 amino acid residues. Two proteins
are involved in the maturation of microcin J25 while an ABC
transporter homologue is involved in transport of and immu-
nity to the bacteriocin (56). Gassericin A is produced by Lac-
tobacillus gasseri as a peptide of 58 amino acid residues with a
33-amino-acid leader. Nothing is known of the maturation or
secretion process of this bacteriocin (32). The Enterococcus
faecalis AS-48 (bac21) primary translation product of 116
amino acid residues is processed to create a cyclic bacteriocin
of 70 amino acids. Four gene products (AS-48B, AS-48C, AS-
48C1, AS-48D) are involved in the production of AS-48. A fifth
gene product (AS-48D1) confers immunity to the bacteriocin
(41). AS-48 has a three-dimensional structure showing homol-
ogy to that of NK-lysin of porcine T cells (22). NK-lysin is a
noncircular protein of 78 amino acid residues that has antibac-
terial and tumorolytic activities (4).
Other cyclic antibacterial peptides exist that are nonriboso-
mally synthesized, like mycosubtilin, gramicidin-S, and tyroci-
dine (11, 13, 43). These peptides can contain, besides L-amino
acids, amino acids in the D configuration and uncommon
amino acids such as ornithine (43).
As a first step towards preventing the growth of Clostridium
tyrobutyricum, a known food spoiler (36), we sought to identify
bacteriocins active against this bacterium. As the activity range
of many bacteriocins is limited to closely related species, we
screened clostridia for production of anti-C. tyrobutyricum ac-
tivities.
In this article, we describe the purification of two novel
antibacterial peptides produced by two different clostridial spe-
cies. Closticin B574 is produced by C. tyrobutyricum ADRIAT
932 and belongs to the class II bacteriocins. Circularin A,
produced by Clostridium beijerinckii ATCC 25752, is shown to
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be a cyclic antibacterial peptide. The bacteriocins were purified
from culture supernatants of the respective producer strains,
and then the structural genes were cloned via reverse genetics
techniques.
MATERIALS AND METHODS
Bacterial strains, media, and reagents. The strains and plasmids used in this
study are listed in Table 1. Clostridia were grown anaerobically at 30°C in
reinforced Clostridium medium (RCM) (Merck, Darmstadt, Germany) or in AC
broth (Difco, Detroit, Mich.) for bacteriocin production. Cultures were grown
anaerobically by flushing with oxygen-depleted nitrogen or by chemical absorp-
tion of the oxygen. Medium was heated for 5 min at 120°C to evacuate gasses and
chilled on ice. After inoculation, a cotton cloth with an equal volume of 10%
pyrogallol (MERCK-Schuchardt, Hohenbrunn, Germany) and saturated sodium
carbonate was applied and the tube was sealed airtight. Plates were incubated in
anaerobic jars with an anaerocult A sachet (Merck). Lactobacilli and pediococci
were grown in MRS at 30 and 37°C, respectively. Twofold-diluted M17 (Difco)
with a final concentration of 1.9% -glycerophosphate and 0.5% glucose (G[1/
2]M17) was used for growth of Listeria innocua and Lactococcus sp. E. coli was
grown in TY broth at 37°C with vigorous agitation. The appropriate media were
supplemented with 1.5% agar for growth of bacteria on agar plates. Ampicillin
was used at a concentration of 100 g/ml, and chloramphenicol and erythromycin
were used in combination at concentrations of 2.5 g/ml each.
General DNA methods and materials. Molecular cloning techniques were
performed essentially as described by Sambrook et al. (52). Restriction enzymes,
T4 DNA ligase, and Expand DNA polymerase were obtained from Roche Di-
agnostics GmbH (Mannheim, Germany) and used as specified by the supplier.
Plasmids were isolated from clostridial strains according to the method of Ander-
son et al. (2).
Tricine–SDS-PAGE. Proteins were separated by Tricine–sodium dodecyl sul-
fate (SDS)-polyacrylamide gel electrophoresis (PAGE) (53) with 20% acryl-
amide (Bio-Rad, Hercules, Calif.). Protein samples were mixed with an equal
volume of 2 Laemmli sample buffer (100 mM Tris [pH 6.0], 20% glycerol, 0.1%
bromophenol blue [Merck]) with or without 4% SDS and 10% -mercaptoetha-
nol. The low-range rainbow marker RPN 755 (Amersham, Roosendaal, The
Netherlands) was used as a protein molecular weight marker. Silver staining was
performed according to the protocol of Wray et al. (62).
Bacteriocin assays. Colony overlay assays were performed. Colonies on a
nutrient plate were treated with chloroform vapor for 15 min. After 30 min of
exposure to air, the colonies were covered with a top agar (0.75%) layer of the
proper growth medium seeded with the indicator strain. After appropriate in-
cubation, 1 to 3 days depending on the indicator strain used, the plates were
examined for halos of growth inhibition. Bacteriocin activity was determined by
a critical dilution assay as described by Geis et al. (20), except that assays were
performed in microtiter plates. To 50 l of serial-diluted bacteriocin-containing
samples, 150 l of medium containing the indicator strain Lactobacillusi sake´
ATCC 15521(pMG36e, pMG36c) was added, unless mentioned otherwise. The
volumes were 100 l for both sample and indicator when clostridia were used as
indicators. After the appropriate incubation time (16 to 24 h for L. sake´ or 3 days
for the clostridia), the microtiter plates were examined for growth inhibition.
Inhibition is seen when the optical density at 600 nm in a well is less then half of
that of a control well without added bacteriocin. The highest dilution of bacte-
riocin still inhibiting growth of the indicator is set to contain 1 arbitrary unit
(AU). Bacteriocin production during growth was determined by growing the
producer anaerobically in AC medium in krim seal bottles in a nitrogen atmo-
sphere. Samples were taken by syringe at regular time points without disturbing
the anaerobicity. To determine bacteriocin activity in a Tricine–SDS-polyacryl-
amide gel, the procedure of Bhunia et al. (7) was used with the following
modifications. Fixation of the gel was done by incubation in 20% isopropanol–
10% acetic acid in water for 30 min at room temperature. Subsequently, the gel
was washed six times with demineralized water, covered with a top agar (0.75%)
layer containing 102 diluted cells of an overnight culture of the indicator L.
sake´, and incubated overnight at 30°C.
Bacteriocin characterization. Screening for bacteriocin production by clos-
tridia was performed by measuring the antibacterial activity of filter-sterilized
supernatants of stationary-phase cultures grown in RCM basically as described
previously (20), except that the experiments were performed in 200-l final
volumes in microtiter plate wells. Microtiter plates were incubated anaerobically
for 3 days before inhibition levels were determined. Additionally, bacteriocin
production on plates was tested by a colony overlay assay. Six clostridial strains
were used as indicators. The proteinase sensitivity of putative bacteriocin activ-
ities was determined by incubating filter-sterilized supernatants of stationary-
phase cultures of bacteriocin-producing strains for 1 h (closticin 574) or 24 h
(circularin A) at 37°C with an equal volume of 1.0 mg of proteinase K (Merck),
thermolysin, alpha-chymotrypsin (Sigma, St. Louis, Mo.), or pronase (Roche)
per ml or 0.78 mg of trypsin (Sigma)/ml in 0.1 M Tris buffer (pH  7.6). The
residual bacteriocin activity was determined in a critical dilution assay. Bacteri-
ocin temperature stability was determined by incubating filter-sterilized super-
natants for 1 h at temperatures ranging from 4 to 90°C. After incubation, samples
were cooled on ice and residual activity was measured in a critical dilution assay.
Antibacterial activity as a result of the presence of a phage in the culture
supernatant was excluded by filtering the culture supernatants through a 0.2-
m-pore-size filter (Schleicher & Schuell, Dassel, Germany) and testing the
filtrate for antibacterial activity. The requirement of disulfide bridges for bacte-
riocin activity was determined by measuring the activity in a critical dilution assay
in the presence of 10 mM dithiothreitol (DTT). The bacteriocin activity range
was determined in a microtiter plate assay. Two hundred microliters of an
exponentially growing culture of an indicator strain, diluted either 1:500 or
1:1,000 in fresh medium, was added to 50 l of bacteriocin-containing superna-
tant. Plates were incubated at the appropriate temperature for 18 h, and growth
was determined by measuring the optical cell density at 600 nm in a microtiter
plate reader (Tecan, Ma¨nnedorf, Switzerland).
Bacteriocin purification. For the purification of circularin A, C. beijerinckii
ATCC 25752 was grown on an AC medium dialysate. The dialysate was obtained
by dialyzing 100 ml of 10 concentrated medium against 900 ml of water by using
a dialysis membrane (Medicell, London, England) with a cutoff of 12 to 14 kDa.
The supernatant of a filter-sterilized culture was precipitated with 50% ammo-
nium sulfate at 4°C for at least 4 h. The precipitate was spun down at 12,000 
g for 30 min at 4°C and dissolved in 30 ml of demineralized water. This solution
was extracted with an equal volume of n-butanol. The n-butanol phase was
freeze-dried, and the resulting pellet was again dissolved in water. This fraction
was further purified by high-performance liquid chromatography (HPLC) with a
C4 column and eluted with a 10 to 90% acetonitrile gradient in a 0.1 to 0.05%
trifluoroacetic acid gradient at 1 ml/min while the absorbance at 214 nm was
TABLE 1. Bacterial strains
Strain Description Reference orsourcea
C. beijerinckii ATCC 25752 Circularin A
producer
NIZO
C. tyrobutyricum NIZO B570 NIZO
C. tyrobutyricum ADRIAT 932 Closticin 574
producer
NIZO
C. tyrobutyricum NIZO B575 NIZO
C. tyrobutyricum CNRZ500 NIZO
C. tyrobutyricum NIZO B590 NIZO
E. faecalis JH2-2 28
E. faecalis OG1X 25
Lactobacillus alimentarius L4 Unilever
Lactobacillus brevis L40 Unilever
Lactobacillus buchneri L4 Unilever






L. sake´ ATCC 15521 Lab collection
L. sake´ IFO12456 Lab collection
L. lactis IL1403 Plasmid free 8







a NIZO, NIZO food research (Ede, The Netherlands). Unilever is located in
Vlaardingen, The Netherlands.
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continuously monitored. The active, bacteriocin-containing fraction after HPLC
was used for N-terminal amino acid sequence determination.
Closticin 574 was purified from the supernatant of a stationary-phase culture
of C. tyrobutyricum ADRIAT 932 grown in AC medium. The culture supernatant
was filter sterilized, and proteins were precipitated with 40% ammonium sulfate
for at least 4 h at 4°C. The precipitate was spun down at 12,000  g for 30 min
and dissolved in 20 ml of demineralized water. This fraction was further purified
with a hydrophobic interaction column (Octyl Sepharose Fast Flow; Amersham)
and fast-performance liquid chromatography (FPLC). The column was washed
with 1.0 M ammonium sulfate in a 50 mM phosphate buffer (pH 7.0) containing
30% isopropanol. Bacteriocin activity was eluted with a 1.0 to 0 M ammonium
sulfate gradient in 50 mM phosphate buffer (pH 7.0) containing 30% isopropanol
at 1 ml/min. Absorbance was monitored at 280 nm. The purified material was
desalted and concentrated with an Ultrafree-4 ultrafiltration column with a
5-kDa cutoff (Millipore, Bedford, Mass.). The retentate was applied to an anion-
exchange column (DEAE Sepharose fast flow; Amersham), washed with 20 mM
Tris-HCl (pH 8.0), and eluted with a 0 to 2.0 M NaCl gradient in 20 mM
Tris-HCl (pH 8.0). The flowthrough was concentrated with an Ultrafree-4 ultra-
filtration column with a 5-kDa cutoff (Millipore). Proteins were further purified
by HPLC with a C4 column, which was eluted with a 10 to 90% acetonitrile
gradient in 0.1% trifluoroacetic acid at 1 ml/min. Absorbance was monitored at
214 nm. Protein purity and quantity were determined by Tricine–SDS-PAGE
and subsequent silver staining.
N-terminal sequence determination. N-terminal amino acid sequencing was
performed at Eurosequence bv (Groningen, The Netherlands). Sequence anal-
ysis was performed by Edman degradation (14, 26) with an automated sequena-
tor (model 494 Procise or model 477a; Applied Biosystems, Warrington, United
Kingdom) (24) and protocols, reagents, chemicals, and materials from Applied
Biosystems.
Nucleotide sequencing. Degenerate primers were designed based on the
amino acid sequences of the internal peptides fragment A and fragment B of
circularin A and on the N-terminal amino acid sequence of closticin B574. Two
primers, 514CB1a1 (5-ATGACNATHGGNTGGGC-3) and 514CB2a2 (5-RT
ANGCDATNGCNCKNGCC-3), were designed based on the circularin A
amino acid sequences and two others, B574-for4 (5-GGNWSNGGNYTNTT
YGGNGGNGC-3) and B574-rev1 (5-GCNCKYTTNCDATYTTNGTCCA-
3), were designed based on the closticin B574 amino acid sequence. DNA
fragments obtained after PCR with these primers on the appropriate chromo-
somal DNA templates were cloned by using the Zero-Blunt TOPO PCR cloning
kit (Invitrogen, Breda, The Netherlands) or in pUC19 digested with SmaI. PCR
products were purified by using the High Pure PCR product purification kit from
Roche. Sequencing was performed with the ALFII system with Cy5-labeled
universal and reverse primers according to the protocols of the supplier (Amer-
sham) with the following modifications: the power for the long-read gels was set
at 15 W and the power for the high-resolution gels was set at 18 W.
Computational analyses. Homology comparisons were performed by using the
basic logical alignment tool (BLAST) as described by Altschul et al. (1). BLAST
searches were performed against the National Center for Biotechnology Infor-
mation nonredundant protein database and the National Center for Biotechnol-
ogy Information microbial genome database. Signal peptides were identified by
using signalP (46). Putative transmembrane helices were identified with the
HMTMM2.0 program (37). Proteinase degradation of bacteriocins was predicted
by the PeptideCutter program, available at the ExPASy molecular biology server.
Dyad symmetry, isoelectric point (pI), and molecular weight were determined by
using the program Clonemanager 4 (SEcentral; Scientific & Educational Soft-
ware).
Nucleotide sequence accession number. The circularin A sequence is available
under GenBank accession no. AY164463, and the closticin 574 sequence is
available under GenBank accession no. AY164462.
RESULTS
Bacteriocin production by clostridia. Twelve clostridial
strains were tested for their ability to inhibit C. tyrobutyricum
B570, a known cheese spoilage bacterium (36). Two of these
strains, C. beijerinckii ATCC 25752 and C. tyrobutyricum
ADRIAT 932 exhibited antibacterial activity towards the indi-
cator strain. The antibacterial activities produced by the C.
beijerinckii strain and the C. tyrobutyricum strain were named
circularin A and closticin 574, respectively, based on the results
presented below and were further characterized. Production of
the antibacterial activities was shown to take place in the ex-
ponential growth phase of each strain although closticin 574
production seems to be completed before the culture enters
the stationary phase. (Fig. 1). The treatment of culture super-
natants with proteinases caused complete loss of closticin 574
activity while circularin A activity was more resistant to pro-
teinase digestion. Circularin A activity was only completely lost
when the supernatant of producing cells was treated with pro-
teinase K (1.0 mg/ml), whereas treatment with other protein-
ases such as thermolysin (1.0 mg/ml), pronase (1.0 mg/ml),
trypsin (0.78 mg/ml), and alpha-chymotrypsin (1.0 mg/ml) re-
sulted in residual antibacterial activity (2 to 100%) even after
24 h of incubation. Samples of circularin A-containing super-
natant after proteinase digestion were analyzed by a gel over-
lay assay. The band of inhibition of growth of the indicator had
not shifted, indicating that digestion products of circularin A
are not the cause of the residual antibacterial activity (data not
shown). These results are indicative of the proteinaceous na-
ture of both antibacterial activities. Incubation at 80 or 90°C
for 1 h causes complete inactivation of both bacteriocins. In-
cubation at somewhat less-elevated temperatures (between 50
and 80°C) causes a significant reduction in closticin 574 activity
while circularin A activity is stable at these temperatures. The
FIG. 1. Bacteriocin production by C. beijerinckii ATCC 25752 and
C. tyrobutyricum ADRIAT 932. Bacterial growth, followed by measure-
ment of the optical density of the cultures at 600 nm, is indicated by
circles and squares, respectively, while bacteriocin activity is shown by
diamonds and triangles, respectively. The optical densities at 600 nm
(OD600) are plotted on the left y axes, while the right y axes show the
bacteriocin activities (in AU per milliliter) in both culture superna-
tants.
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bacteriocins do not seem to be extremely oxygen sensitive, as
both inhibit L. sake´ ATCC 15521 in the presence of oxygen. All
of these properties define both antibacterial activities as bac-
teriocins. DTT did not destroy the activity of either bacteriocin
(data not shown), indicating that both probably do not contain
the disulfide bridges necessary for antibacterial activity.
The activity spectrum of both bacteriocins was determined
(Table 2). Circularin A has the widest activity range, inhibiting
all C. tyrobutyricum strains tested and also lactococci, entero-
cocci, and some Lactobacillus strains. Closticin 574 also inhib-
its all C. tyrobutyricum strains tested, except for the producer
strain, and some lactobacilli but not the enterococci and Lac-
tococci tested. Circularin A and closticin 574 are both small
proteins. The supernatant of C. beijerinckii ATCC 25752 pro-
duced a band of inhibition at a position of a protein of 2.2 kDa
in a gel overlay assay (Fig. 2). The supernatant of the closticin
574 producer gave a growth-inhibition halo at the position of a
protein of approximately 7 kDa (Fig. 2). When 2 Laemmli
sample buffer with SDS and -mercaptoethanol was used for
sample preparation, no activity of closticin 574 was observed in
the gel overlay assay. Omitting SDS and -mercaptoethanol
solved this problem. Circularin A was not affected by these
constituents of the sample buffer. These results indicate that
closticin 574, unlike circularin A, is sensitive to denaturing
conditions.
Circularin A purification. The initial purification of circula-
rin A was performed by using nondialyzed complete AC me-
dium. However, impurity of the bacteriocin preparation with
medium peptides precluded proper determination of the N-
terminal amino acid sequence of circularin A. The use of
dialyzed medium (see Materials and Methods) solved this
problem. Production in dialyzed medium was between 8- to
38-fold lower than production in complete medium. The total
bacteriocin activity in a stationary-phase culture grown in dia-
lyzed medium was approximately 6.4  104 AU/ml. Using 50%
ammonium sulfate, 31% of the activity could be precipitated.
The precipitate was dissolved in demineralized water and ex-
tracted with n-butanol. No antibacterial activity was lost during
this step of the isolation procedure. The n-butanol fraction was
lyophilized, the residue was dissolved in water, and the sample
was subjected to HPLC purification. Bacteriocin activity eluted
in two peaks of which the first had the highest antibacterial
activity (50 to 70% of the total activity applied). The second
peak had less than 1% of the antibacterial activity of the first
peak. Whether this peak is related to circularin A or is caused
by another bacteriocin is unknown. Because of the low level of
bacteriocin activity it was not further studied. The purified
protein in the first peak was judged pure by Tricine–SDS-
PAGE and silver staining, and the amount was estimated to be
approximately 100 pmol (data not shown).
Internal amino acid sequence of circularin A and identifi-
cation of the cirA structural gene by reverse genetics. Initial
attempts to determine the N-terminal amino acid sequence of
purified circularin A failed, indicating that the N terminus may
be blocked. After cyanogen bromide (CnBr) cleavage of the
protein, a mixture of two signals was obtained during N-ter-
minal sequencing. This result indicated that the protein was cut
into two fragments and contained at least two methionine
residues. The mixture of fragments (A and B) after CnBr
cleavage was purified by HPLC-C18, and the N-terminal amino
acid sequence of fragment A was determined (Fig. 3). Com-
bining the amino acid sequence of this fragment with the N-
terminal amino acid sequence determined on the fragment
mixture obtained after CnBr cleavage enabled deduction of the
amino acid sequence of fragment B (Fig. 3).
In C. beijerinckii ATCC 25752, no plasmids could be de-
tected (data not shown), and therefore, the genes for bacteri-
ocin production are chromosomally located. Based on the
amino acid sequences of the two fragments A and B, a number
of degenerate primers were designed and used in different
combinations as the relative orientation of fragments A and B
was a priori unknown. A 75-bp PCR fragment was obtained
from chromosomal DNA from C. beijerinckii ATCC 25752 with
primers 514CB1a1 and 514CB2a2. This result indicated that
the fragments A and B occur in the order A to B in the
bacteriocin (Fig. 3). The PCR fragment was subcloned in
FIG. 2. Circularin A and closticin 574 activity in a Tricine–SDS-
PAGE gel overlay assay. Lanes: 1, 0.125 l of C. beijerinckii ATCC
25752 supernatant; 2, 7.5 l of C. tyrobutyricum ADRIAT 932 super-
natant; M, 4 l of Rainbow molecular weight marker RPN 755. The
band of inhibition in lane M corresponds to lysozyme activity. The
indicator strain used was L. sake´ ATCC 15521.
TABLE 2. Activity spectrum of circularin A and closticin 574
Indicator strain
Resulta for:
Circularin A Closticin 574
C. beijerinckii ATCC 25752  
C. tyrobutyricum NIZO B570  
C. tyrobutyricum ADRIAT 932  
C. tyrobutyricum NIZO B575  
C. tyrobutyricum CNRZ500  
C. tyrobutyricum NIZO B590  
E. faecalis JH2-2  
E. faecalis OG1X  
Lactobacillus alimentarius L4  
Lactobacillus brevis L40  
Lactobacillus buchneri L4  
Lactobacillus casei subsp. casei L37  
Lactobacillus plantarum lacC  
Lactobacillus sake´ ATCC 15521  
Lactobacillus sake´ IFO12456  
L. lactis IL1403  
L. lactis MG1363  
Pediococcus pentosaceus FBB61-2  
Pediococcus pentosaceus PPE 1.2  
a , inhibition; , no inhibition of the indicator strain by 5-diluted culture
supernatant of C. beijerinckii ATCC 25752 (circularin A producer) or C. tyrobu-
tyricum ADRIAT 932 (closticin 574 producer) in a microtiter plate assay.
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pUC19 and sequenced. The entire structural gene of circularin
A was subsequently cloned by inverse PCR techniques and
sequenced (Fig. 3). The sequence is available under GenBank
accession no. AY164463. CirA codes for a peptide of 72 amino
acid residues. The gene is preceded by a proper Shine-Dal-
garno sequence (AAGGAGGT) at a distance of 6 nucleotides
upstream of the translation initiation codon. Putative 35 (TT
GCGA) and 10 (TATCAA) sequences are present. A large
palindromic structure (G0  20.7 kcal) is present down-
stream of cirA. Performing a BLAST search with the derived
FIG. 3. Nucleotide sequence of cirA and circularization of circularin A. The fragments A (underlined), B (boldface), and B extended (boldface
and italic) are indicated throughout the figure. (A) Amino acid sequences of fragments A and B of CnBr-cleaved circularin A. The sequence of
fragment A was obtained by Edman degradation on a purified fragment of CnBr-cleaved circularin A. The sequence of fragment B was obtained
by deduction as described in the text. The extended sequence of fragment B was used to determine the circularization point. The degenerate
nucleotide sequences of the primers (514CB1a1 and 514CB2a2) used to obtain an internal cirA DNA fragment by PCR (dotted line) are indicated.
(B) Nucleotide and deduced amino acid sequences of the structural gene of circularin A (cirA). The vertical arrow indicates the circularization
point. Putative Shine-Dalgarno (S.D.) and promoter sequences are underlined. Translation starts with a formyl-methionine (fMet). Two large
arrows indicate an inverted repeat downstream of cirA. (C) Putative maturation process of circularin A. The peptide bond between Leu3 and Val4
is cleaved, and a new bond is formed between Tyr72 and Val4. The reaction yields the peptide MFL and the circular bacteriocin. The thin line in
the pre-CirA sequence is a schematic representation of the newly forming peptide bond.
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circularin A amino acid sequence revealed that the protein has
60% similarity (30% identity) with the E. faecalis bacteriocin
AS-48 (40). AS-48 is a circular molecule, and the purified
peptide was also blocked at the N terminus (40). Continuing
the N-terminal amino acid sequence reactions on the CnBr-
cleaved fragment mixture, the sequence of fragment B was
extended. In this way it was shown that circularin A is also a
circular peptide. It also allowed determination of the exact
point of circularization (Fig. 3). Mature circularin A contains
69 amino acids. It is formed by the removal of a leader of three
amino acid residues from the preprotein and head-to-tail liga-
tion between the processed N terminus and the C terminus.
Circularin A has high pI of 10.60 as calculated on the noncir-
cular form of the mature bacteriocin, which is common for
bacteriocins.
Purification of closticin 574. The supernatant of a producing
culture of C. tyrobutyricum ADRIAT 932 containing 6.4  107
AU of bacteriocin activity was precipitated with 40% ammo-
nium sulfate. In this way, 80% of the total activity was recov-
ered. The precipitate, dissolved in 20 ml of 50 mM phosphate
buffer (pH 7.0) with 30% isopropanol and 1.0 mM ammonium
sulfate, was purified by FPLC with an ammonium sulfate gra-
dient (see Materials and Methods). Bacteriocin activity eluted
around 300 mM ammonium sulfate with 30% isopropanol, and
the recovery of activity after the FPLC step was 100%. The
pooled active fractions were concentrated by ultrafiltration and
DEAE-column chromatography applying a NaCl gradient. Of
the total activity, 35% was present in the flowthrough while
18% of the activity eluted between 1.6 and 2.0 M NaCl. The
loss of bacteriocin activity could be caused by degradation
and/or chemical modification of the bacteriocin or could indicate
that the total bacteriocin activity is based on more than one
protein. The flowthrough was concentrated by column ultrafiltra-
tion and subjected to HPLC. The activity retrieved after this step
was only about 20% of that applied to the column. The quantity
(10 to 20 pmol) and purity were sufficient, as judged by Tricine–
SDS-PAGE and silver staining, to allow for N-terminal amino
acid sequence determination by Edman degradation.
FIG. 4. Nucleotide and derived amino acid sequences of closticin 574. (A) N-terminal amino acid sequence of closticin 574 as determined by
Edman degradation on the purified protein. Amino acids within parentheses were determined with a confidence level of 	90% certainty.
Parenthetic amino acids with a question mark obtained a confidence level of 50%. At position 16, signals of both Ala and Gly were derived,
probably as a consequence of high background levels of glycine. (B) Nucleotide and deduced amino acid sequences of the structural gene of
closticin 574 (cloA). The deduced amino acid sequence of mature closticin 574 is indicated in boldface. The predicted N-terminal signal sequence
is underlined. Putative Shine Dalgarno (S.D) and promoter sequences are underlined. The putative UUG start codon is indicated in boldface.
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N-terminal amino acid sequence of closticin 574 and isola-
tion of the cloA structural gene. The 27 N-terminal amino acid
residues of purified closticin 574 were determined (Fig. 4).
Degenerate primers B574-for4 and B574-rev1 were designed
based on this sequence and used for inverse PCR on Sau3A-
digested and self-ligated C. tyrobutyricum ADRIAT 932 chro-
mosomal DNA. A 265-bp PCR fragment was obtained, cloned
in the pCR-Blunt II-TOPO vector, and sequenced. Based on
the obtained sequence, primers were designed and used for
further PCR and sequencing. The nucleotide sequence of the
structural gene of closticin 574 (cloA) is presented in Fig. 4.
The sequence is available under GenBank accession no.
AY164462. From the nucleotide and N-terminal amino acid
sequence data, closticin 574 is concluded to be initially pro-
duced as a preproprotein of 310 amino acid residues. It is
subsequently processed to a bacteriocin of 82 amino acids with
a pI of 9.9. The protein has an unusually long preproprotein
sequence of 228 amino acids. Translation initiation putatively
starts at a rare UUG start codon. A putative ribosome binding
site (GGAG) is present 5 nucleotides upstream of this start
codon, and the cloA gene is preceded by putative 35 (CTG
AAA) and 10 (GATAAT) sequences. The deduced amino
acid sequence of cloA is almost identical to the sequence ob-
tained by Edman degradation. Arg9 and Arg15 in the Edman
degradation profile are actually cysteine and tryptophan resi-
dues, respectively, in the deduced peptide. CloA is homolo-
gous to the deduced products of two unknown open reading
frames of Corynebacterium diphtheriae (http://www.sanger
.ac.uk) and to one unknown product of Corynebacterium glu-
tamicum (accession no. AX127147). The first 27 amino acids of
the primary translation product of cloA were identified as a
signal sequence by the SignalP program (Fig. 4).
DISCUSSION
Closticin 574 is, on the basis of the nucleotide sequence of its
structural gene, produced as preproprotein of 309 amino acid
residues. After secretion and processing, it gives rise to an
antimicrobial peptide of 82 amino acid residues. The first 27
amino acids of the full-length protein probably constitute a
general signal peptide, as predicted by the SignalP program.
General signal peptides are uncommon for bacteriocins, al-
though some bacteriocins, such as enterocin P, divergicin A,
and listeriocin (9, 30, 61), are secreted via the general secretion
pathway. Furthermore, secretion of a bacteriocin that normally
is externalized by dedicated, sec-independent secretion systems
can be accomplished by fusing it to a signal peptide directing
the heterologous protein to the general secretion pathway (5,
42). The predicted secretion of CloA via the sec pathway and
subsequent processing of the putative signal peptide would not
yield the bioactive peptide. The secreted protein is most prob-
ably further processed extracellularly either by a general or by
a specific proteinase. Such a mechanism of bacteriocin activa-
tion has been observed before. The bacteriocin Lsb1 of Lac-
tococcus lactis, for instance, has been recently shown to be
processed, and thus activated, after secretion by the cell wall
proteinase HtrA (16a). It is also possible that the aspartyl-
prolyl bond (Asp227-Pro228) at which cleavage in closticin 574
has taken place is chemically broken to create the active pep-
tide, as is the case for guanylin (54). However, despite the fact
that the N-terminally sequenced protein was active, we cannot
exclude the possibility that the cleavage of the Asp227-Pro228
bond is the result of the purification method, as Asp-Pro bonds
are easily hydrolyzed under acidic conditions (38, 48). During
purification of closticin 574, such acidic conditions are encoun-
tered in the HPLC step when the sample is eluted in the
presence of trifluoroacetic acid, a very acidic compound.
Cleavage of Asp-Pro bonds during protein purification has
been observed previously (16, 54, 55, 57).
The cysteines present in closticin 574 are not involved in the
formation of a disulfide bridge required for activity since DTT
treatment did not inactivate the protein. With all data taken
together, closticin A classifies as a class IIc bacteriocin, al-
though it is exceptional for its unusual maturation process. The
classification is based on its sensitivity for proteinases and the
relatively small size (82 amino acid residues) (35) of the pro-
cessed prepropeptide. Closticin A is not structurally modified
like the class I bacteriocins (51), since none of the character-
istic residues and problems typical when sequencing proteins
contain lanthionine, -methyllanthionine, or dehydroalanine
residues (51) were encountered during N-terminal sequencing.
The bacteriocin does not contain the YGNGVXAAC consen-
sus motif of the pediocin-like bacteriocins (15), nor are two
different peptides required for activity, as is the case for lac-
tococcin G, lactococcin M/N, and plantaricins EF and JK (3,
47, 61).
Circularin A is produced as a preprotein of 72 amino acids
that is processed to a circular peptide of 69 amino acid resi-
dues. The preprotein is circularized by the hydrolysis of the
peptide bond between Leu3 and Val4 and the formation of a
new bond between Val4 and the C-terminal Tyr72 (Fig. 3). This
head-to-tail linkage has so far only been described for three
other proteins, gassericin A, microcin J25, and AS-48, all of
which are antibacterial peptides (6, 31, 40). The circularization
of microcin J25 is accomplished by two dedicated proteins (56).
For AS-48, it is not known which proteins, out of four different
proteins involved in the production of the active bacteriocin,
are responsible for the actual circularization (41). The actual
location at which circularization takes place is not known for
any of the four bacteriocins. The homology between the two
systems for production of microcin J25 or AS-48 is limited to
the presence of an ATP-binding site in one of the proteins
involved in each case. Circularin A is similar to AS-48 but,
interestingly, lacks the extended leader of AS-48 (40). Only the
first three N-terminal amino acids of pre-CirA are cleaved off
to allow the formation of a peptide bond between Val4 and
Tyr72. The three other circular bacteriocins are translated with
longer leader peptides of 33, 35, and 37 residues for gassericin
A, AS-48, and microcin J25, respectively (6, 31, 40).The ques-
tion arises as to whether the 3-amino-acid-long leader in pre-
CirA has a function in targeting the protein for secretion or
processing, as do the signal peptides and the double glycine
leaders of other bacteriocins (23, 60). Some bacteriocins are
known to be secreted without the need for a leader peptide (9,
16a, 45), but these bacteriocins are not modified nor is the
transport machinery dedicated to that bacteriocin. It has been
postulated that in those cases the overall charge is the recog-
nizing factor (16a). Another possibility might be that the signal
directing the protein for modification and secretion is embed-
ded within the peptide, as has been shown for hemolysin (34),
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some metalloproteinases (21), and some peroxisomal proteins
(58). That a few amino acid residues can already have a tar-
geting function has been shown for the peroxisome-targeting
signals PTS1 and PTS2. PTS1 is a conserved C-terminal trip-
eptide sequence while PTS2 is a nonapeptide sequence located
near the N terminus or at internal locations of the protein to be
targeted (58). If the 3-amino-acid residue leader peptide of
pre-circularin A embeds a targeting function, it would be the
smallest leader peptide known.
Circularin A is highly resistant to digestion by sequence-
specific endoproteinases. This is not due to absence of diges-
tion sites, since sites for trypsin (Lys-X, Arg-X), alpha-chymo-
trypsin (FYW-X [not P,M]), and thermolysin (X [not D,E]-A,
F, I, L, M, V) are present in circularin A. This same resistance
to proteolytic digestion has been observed for microcin J25 (6).
AS-48 was resistant to digestion with alpha-chymotrypsin (29)
but was hydrolyzed by trypsin, pronase, and proteinase K (17).
We presume that the resistance to proteolytic hydrolysis is due
to the inaccessibility of the recognition sites. This notion seems
to be supported by the three-dimensional structure of the cir-
cularin A homologue AS-48. AS-48 is a tightly folded globular
peptide consisting of 5 
-helices, resembling the typical sa-
porin fold as observed in NK-lysin, a porcine antibacterial
peptide from NK and T cells (22). The functionality of such
resistance towards proteinases could be to make the protein
less susceptible to digestion by proteinases of target bacteria,
thereby increasing the activity range of the bacteriocin. For
instance, the natural cell wall proteinases PrtPI and PrtPIII of
L. lactis digest bacteriocins such as LcnB, LcnA, and Lsb2
(16a) but are unable to digest circularin A (unpublished data).
Classification of the circular bacteriocins circularin A, mi-
crocin J25, gassericin A, and AS-48 in either of the current
bacteriocin classes I to III is not justifiable. They are riboso-
mally synthesized and posttranslationally modified small bac-
teriocins, which makes them fall out of bacteriocin classes II
and III. Due to the fact that they do not contain modified
amino acids, they do not belong to the class I bacteriocins, and
since they are not complex proteins composed of a protein plus
another chemical moiety (lipid or carbohydrate) needed for
activity, they cannot be in class IV. We therefore propose to
distinguish a new class, class V, of bacteriocins consisting of
ribosomally synthesized nonmodified head-to-tail-ligated cyclic
antibacterial peptides. Characteristic of class V bacteriocins is
their cyclization by formation of a peptide bond between the N
and C termini of a processed prepeptide. This process of
leader peptide removal, circularization, and secretion puta-
tively involves dedicated enzymatic reactions. These enzymatic
reactions are most probably encoded by the genes in the direct
vicinity of the structural gene (unpublished data).
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